Granules India plant passes FDA inspection; Aurobindo building warehouse in New Jersey;

> Granules India reported that the FDA inspected its plant in Gagillapur near Hyderabad in response to an ANDA and had no observations. Report

> Indian drugmaker Aurobindo will build a new warehouse and hire 300 workers in East Windsor, NJ. Report

> Porton Fine Chemicals of Chongqing, a Chinese contract manufacturer of intermediates, will acquire competitor Jiangxi Dongbang Pharmaceutical in a $41.5 million deal. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.